LungNet: Leveraging state-space models with SE-enhanced skip connections for precise CT-based lung lesion segmentation

Lung cancer, which accounted for 2.48 million new cases and 1.82 million deaths worldwide in 2022, continues to be the most lethal cancer across the globe, underscoring the urgent demand for more advanced diagnostic tools. Although computed tomography (CT) imaging has long been central to lung cancer detection, the heterogeneous and complex characteristics of lung lesions make accurate segmentation particularly challenging. Current deep learning methods face a critical bottleneck: convolutional neural networks (CNNs) often struggle to capture long-range dependencies due to limited receptive fields, while Transformer-based architectures incur prohibitive computational costs when processing high-resolution CT volumes. Furthermore, standard skip connections in traditional UNet models frequently introduce redundant noise, leading to the dilution of subtle lesion features. To address these specific technical gaps, we introduce a novel deep learning framework that integrates Mamba state-space models with an improved UNet architecture. In this design, to mitigate feature redundancy, Squeeze-and-Excitation networks are embedded into skip connections, while auxiliary losses are introduced to address the degradation of shallow features and capture fine-grained lesion features across varied morphologies. Such a framework not only accommodates the intricate differences in lesion size, shape, and spatial distribution but also achieves a balance between global context modeling and linear computational efficiency. By uniting the local feature extraction strengths of convolutional layers with the long-range dependency modeling power of state-space models, our approach achieves more precise delineation of lung lesion boundaries. Extensive experiments conducted on multiple datasets provide compelling evidence of the method’s effectiveness: it attains state-of-the-art segmentation accuracy and demonstrates significant promise for enhancing early detection, ongoing disease monitoring, and treatment planning in lung cancer patients. This advancement delivers a robust solution for the inherently complex task of lung lesion segmentation. Moreover, because lung cancer treatment is costly and insurance coverage plays a decisive role in distributing expenses, the study’s outcomes also carry considerable implications for the insurance sector.